Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2023-11-13 00:00:00 ET · period of report 2023-11-10 · accession 0001846487-23-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-13 | 2023-11-10 | ANIP | Mutz Christopher | HEAD OF RARE DISEASE | S - Sale | $52.47 | -3,000 | 63.6K | -5% | -$157.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-10 | S | D | 3,000 | $52.47 | 63,607 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $52.41 to $52.58, inclusive. |